I thought PAA already had 4 of the 6 required for Cohort 2? The benefits of having Trial Patients still on Medication is that recruitment should become easier as the MND community is very tight knit , so hopefully those that are participating will encourage other MND sufferers to participate.
We all know No one likes to be first , I can only commend all trial patients for their involvement .. thank you NZT
PAA Price at posting:
8.1¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)